|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007226,
umls-concept:C0010068,
umls-concept:C0030705,
umls-concept:C0038952,
umls-concept:C0074554,
umls-concept:C0240951,
umls-concept:C0301630,
umls-concept:C0441471,
umls-concept:C0936012,
umls-concept:C0948265,
umls-concept:C1515021,
umls-concept:C2603343
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2004-6-28
|
|
pubmed:abstractText |
To assess the effect of simvastatin treatment on the risk of cardiovascular events in nondiabetic patients with coronary heart disease (CHD) with and without the metabolic syndrome, as defined by the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP-III).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0149-5992
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1735-40
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15220255-Cardiovascular Diseases,
pubmed-meshheading:15220255-Coronary Disease,
pubmed-meshheading:15220255-Double-Blind Method,
pubmed-meshheading:15220255-Follow-Up Studies,
pubmed-meshheading:15220255-Humans,
pubmed-meshheading:15220255-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:15220255-Metabolic Syndrome X,
pubmed-meshheading:15220255-Middle Aged,
pubmed-meshheading:15220255-Placebos,
pubmed-meshheading:15220255-Simvastatin,
pubmed-meshheading:15220255-Time Factors
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S).
|
|
pubmed:affiliation |
Department of Medicine, Kuopio University Hospital, Kuopio, Finland. kalevi.pyorala@uku.fi
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
